𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting the outcome in non-Hodgkin lymphoma with molecular markers

✍ Scribed by Yok-Lam Kwong

Book ID
108675203
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
563 KB
Volume
137
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated serum endostatin is associated
Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma
✍ Petri Bono; Lasse Teerenhovi; Heikki Joensuu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND Endostatin is a cleaved fragment of collagen Type XVIII and has antiangiogenic activity. The clinical significance of circulating, soluble endostatin (S‐endostatin) is not known. ## METHODS Pretreatment S‐endostatin and serum vascular endothelial growth factor (S‐VEGF)

Mutations and molecular variants of the
Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma
✍ Karen M. Cerosaletti; V. Anne Morrison; Daniel E. Sabath; Dennis M. Willerford; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract Non‐Hodgkin lymphomas (NHLs) are characterized by chromosomal translocations that juxtapose loci encoding lymphoid antigen receptors with cellular proto‐oncogenes. These translocations are thought to arise from inaccurate processing of DNA breaks created during physiologic recombination

Non-melanoma skin cancer may be a marker
Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma
✍ Henrik Hjalgrim; Morten Frisch; Hans H. Storm; Bengt Glimelius; Jakob Bøje Peder 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 2 views

According to recent results, patients with non-melanoma skin cancers are at increased risk of developing non-Hodgkin's lymphoma (NHL). The prognostic significance of this association is unknown. Two cohorts of patients with a first diagnosis of non-melanoma skin cancer and a subsequent diagnosis of